American International Group’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

American International Group’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-27,615	Closed	-$40K	–	5183
2016 Q1	$40K	Hold	27,615	–	–	﹤0.01%	3998
2015 Q4	$89K	Sell	27,615 -48	-0.2%	-$231	﹤0.01%	3566
2015 Q3	$173K	Buy	27,663 +32	+0.1%	+$299	﹤0.01%	2968
2015 Q2	$274K	Buy	27,631 +3,298	+14%	+$28.9K	﹤0.01%	2731
2015 Q1	$179K	Hold	24,333	–	–	﹤0.01%	3055
2014 Q4	$130K	Buy	24,333 +907	+4%	+$4.64K	﹤0.01%	3341
2014 Q3	$118K	Sell	23,426 -618	-3%	-$3.8K	﹤0.01%	3422
2014 Q2	$161K	Buy	24,044 +23,444	+3,907%	+$149K	﹤0.01%	3188
2014 Q1	$4.34K	Sell	600 -500	-45%	-$2.96K	﹤0.01%	4570
2013 Q4	$4.15K	Buy	+1,100	New	+$4.26K	﹤0.01%	4492

Other funds holding NWBO

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

American International Group's NWBO Position: Q2 2016 in Review

American International Group sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q2 2016, closing a stake of 27,615 shares — an estimated $40K sold.

American International Group first reported a position in NWBO in Q4 2013 and held it in 10 quarters. The position peaked at $274K in Q2 2015. 64 funds tracked by Wall St. Rank hold NWBO as of Q2 2016.

American International Group reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q2 2016 after selling out during the quarter.
American International Group sold 27,615 Northwest Biotherapeutics, Inc. Common stock shares in Q2 2016, an estimated $40K.
American International Group first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q4 2013 and held it in 10 quarters.
American International Group's Northwest Biotherapeutics, Inc. Common stock position peaked at $274K in Q2 2015.
64 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.